| 今开：21.322 | 昨收：22.95 |
| 最高：22.7899 | 最低：20.84 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.321047444E9 |
Corcept Therapeutics(CORT)02-14 06:05
$Corcept医疗(CORT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020680 Act: 34 Size: 13 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-14 09:55
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-014883 Size: 5 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-16 04:55
$Corcept医疗(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000003 Act: 33 Size: 4 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-16 05:25
$Corcept医疗(CORT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-005055 Act: 34 Size: 7 MB 网页链接查看全文
Corcept Therapeutics(CORT)03-06 10:25
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026782 Size: 9 KB 网页链接查看全文
Corcept Therapeutics(CORT)03-06 09:45
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026707 Size: 11 KB 网页链接查看全文
丰硕创投04-17 17:46
$Corcept Therapeutics(CORT)$ 2024年1月2日，Corcept公司的糖皮质激素受体拮抗剂Korlym®（米非司酮），乃FDA首个批准用于治疗库欣综合征的药物，法院裁决Teva制药公司不侵犯该司专利号10195214和10842800。查看全文
Corcept Therapeutics(CORT)04-17 18:15
$Corcept Therapeutics(CORT)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-098492 Act: 34 Size: 144 KB 网页链接查看全文
Corcept Therapeutics(CORT)03-02 06:35
$Corcept医疗(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-001711 Act: 33 Size: 6 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-14 09:25
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-014874 Size: 5 KB 网页链接查看全文
$Corcept Therapeutics(CORT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-100927 Act: 34 Size: 13 KB 网页链接
$Corcept Therapeutics(CORT)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-016598 Act: 34 Size: 11 MB 网页链接
$Corcept Therapeutics(CORT)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-098492 Act: 34 Size: 144 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-044185 Size: 12 KB 网页链接
$Corcept Therapeutics(CORT)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015633 Act: 34 Size: 3 MB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042725 Size: 9 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000010 Act: 33 Size: 5 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041450 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041435 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002675 Act: 33 Size: 6 KB 网页链接